EX-21.1 4 gyre-ex21_1.htm EX-21.1

EXHIBIT 21.1

SUBSIDIARIES OF GYRE THERAPEUTICS, INC.

Note: Gyre Therapeutics, Inc. or one of its Subsidiaries has 100% ownership of the Subsidiaries listed below, except for Beijing Continent Pharmaceuticals Co., Ltd. (65.2%) and Beijing Continent Biomedical Technology Co., Ltd (65.2%).

Subsidiaries | Jurisdiction
Further Challenger International Limited | British Virgin Islands
Nepenthe Holdings Limited | Hong Kong
Ratel Holdings Limited | British Virgin Islands
Aaring Limited | Hong Kong
Rosefinch Holdings Limited | British Virgin Islands
Continent Pharmaceuticals Inc. | Cayman Islands
BJContinent Pharmaceuticals Limited | Hong Kong
Beijing Continent Pharmaceuticals Co., Ltd. | People’s Republic of China
Beijing Continent Biomedical Technology Co., Ltd. | People’s Republic of China